Vanta Bioscience Ltd.

BSE: 540729 SECTOR: Miscellaneous

128.25
-1.75 (-1.35%)
BSE: 20 Sep 05:10 PM

Price Summary

Today's High

₹ 132.5

Today's Low

₹ 124

52 Week High

₹ 195.5

52 Week Low

₹ 120

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.

Company Essentials

Market Cap

80.95 Cr.

Enterprise Value

95.01 Cr.

No. of Shares

0.63 Cr.

P/E

172.24

P/B

3.45

Face Value

₹ 10

Div. Yield

0%

Book Value (TTM)

₹  37.14

CASH

0.09 Cr.

DEBT

14.15 Cr.

Promoter Holding

69.11%

EPS (TTM)

₹  0.74

Sales Growth

13.61%

ROE

4.28 %

ROCE

8.86 %

Profit Growth

40.97 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Ratios

Sales Growth

1 Year13.61%
3 Year∞%
5 YearNA

Profit Growth

1 Year40.97%
3 Year∞%
5 YearNA

ROE%

1 Year4.28%
3 Year2.7%

ROCE %

1 Year8.86%
3 Year6.71%

Debt/Equity

0.6035

Price to Cash Flow

25.54

Interest Cover Ratio

1.6611276350342

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2021 69.11 0
Sep 2020 69.93 0
Mar 2020 69.93 0
Sep 2019 69.93 0
Mar 2019 69.93 0
* Figures given above are % of equity capital

 Strengths

  • Company has a healthy liquidity position with current ratio of 2.42061235329446.
  • The company has a high promoter holding of 69.11%.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • Company has a poor ROE of 2.69822107623928% over the past 3 years.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high PE of 172.24.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.
Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020
Net Sales 0 3.88 12.08 13.72
Total Expenditure 0 2.85 8.81 9.41
Operating Profit 0 1.03 3.27 4.32
Other Income 0 0.05 0.23 0.11
Interest 0 0.2 1.69 1.95
Depreciation 0 0.57 0.71 1.19
Exceptional Items 0 0 0 0
Profit Before Tax 0 0.31 1.1 1.29
Tax 0 0.29 0.4 0.31
Net Profit 0 0.03 0.69 0.98
Adjusted EPS (Rs.) 0 0.05 1.1 1.55

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2017 Mar 2018 Mar 2019 Mar 2020
Equity and Liabilities
Share Capital 3.65 5.73 6.31 6.31
Total Reserves 2.5 10.86 15.93 17.13
Borrowings 7.5 9.98 12.17 10.43
Other N/C liabilities 0 0.23 0.4 0.59
Current liabilities 0.1 2.4 3.3 7.29
Total Liabilities 13.75 29.19 38.12 41.74
Assets
Net Block 12.95 17.49 17.9 20.76
Capital WIP 0 2.34 3.7 0
Intangible WIP 0 0 0 0
Investments 0 0 2 3
Loans & Advances 0.27 0.35 0.35 0.35
Other N/C Assets 0 0 0 0
Current Assets 0.53 9.01 14.17 17.64
Total Assets 13.75 29.19 38.12 41.74
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020
Profit from operations 0 0.31 1.1 1.29
Adjustment 0 0.73 2.4 3.14
Changes in Assets & Liabilities -0.26 -7.8 -3.56 -1.26
Tax Paid 0 0 0 0
Operating Cash Flow -0.26 -6.75 -0.06 3.17
Investing Cash Flow -12.95 -7.53 -4.48 -1.35
Financing Cash Flow 13.66 13.93 4.73 -2.02
Net Cash Flow 0.44 -0.36 0.2 -0.2

Corporate Actions

Investors Details

PARTICULARS Mar 2019 Sep 2019 Mar 2020 Sep 2020 Mar 2021
Promoters 69.93 69.93 69.93 69.93 69.11
chandra sekhar rao simhad... 1.58 1.58 1.58 1.58 1.58
dopesh raja mulakala 7.26 7.26 7.26 7.26 7.26
m sajan kiran 0.32 0.32 0.32 0.32 0.32
mohan krishna mulakala 55.22 55.22 55.22 55.22 55.22
mulakala karishma 0.79 0.79 0.79 0.79 0.79
pradeep chowdary veeramac... 1.27 1.27 1.27 1.27 0.45
shravan chintapatla 1.27 1.27 1.27 1.27 1.27
soumya simhadri 1.43 1.43 1.43 1.43 1.43
vyas madhavrao shingatger... 0.79 0.79 0.79 0.79 0.79
PARTICULARS Mar 2019 Sep 2019 Mar 2020 Sep 2020 Mar 2021
Public 30.07 30.07 30.07 30.07 30.89
hridaan chopraa 1.38 1.4 1.4 1.4 1.4
rudra murthy vibhushankar... 1.05 1.05 0 0 0
s s seema 0 1.05 1.05 1.07 1.07
vimalchand a . 0 1.06 1.2 1.13 1.14
PARTICULARS Mar 2019 Sep 2019 Mar 2020 Sep 2020 Mar 2021
FII/DII 0 0 0 0 0

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.
Report us

Vanta Bioscience Stock Price Analysis and Quick Research Report. Is Vanta Bioscience an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Vanta Bioscience has a PE ratio of 172.240128928284 which is high and comparatively overvalued .

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Vanta Bioscience has ROA of 2.44921289748637 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Vanta Bioscience has a Current ratio of 2.42061235329446 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Vanta Bioscience has a ROE of 4.28149980210933 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Vanta Bioscience has a D/E ratio of 0.6035 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Vanta Bioscience has an Inventory turnover ratio of 1.21394414027366 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Vanta Bioscience has reported revenue growth of 13.6053375193503 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Vanta Bioscience for the current financial year is 31.4516663894106 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Vanta Bioscience is Rs 0 and the yield is 0 %.

Brief about Vanta Bioscience

X